Close  
  • share this

FDA suspends sale, distribution of Dengvaxia

/ 07:47 AM December 05, 2017

The Food and Drugs Administration (FDA) has suspended the sale, distribution, and marketing of the anti-dengue vaccine Dengvaxia in the Philippines, according to a TV news report.

ADVERTISEMENT

The report aired over at GMA7’s ‘Unang Hirit’ said FDA issued the suspension order to Sanofi Pasteur, the vaccine’s manufacturer, on Tuesday morning.

Sanofi earlier disclosed possible harmful effects on children who’ve been administered the vaccine but who have not contracted dengue.

FEATURED STORIES

The government has initiated a series of probes into the case. /au

Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Dengvaxia, Food and Drug Administration, Health, medicine, news, Sanofi Pasteur, suspension
For feedback, complaints, or inquiries, contact us.
entertainment

Oscar nominees in main categories

February 24, 2019 11:48 AM

newsinfo

British arrested for shoplifting two flat screen TVs

February 24, 2019 11:37 AM

lifestyle

BTS launches Armypedia

February 24, 2019 11:35 AM




© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.